Based on the results of a new study from Penn Medicine, use of a hormone, arginine vasopressin (AVP), reduced the need for blood and blood products by 50% in trauma patients with severe blood loss.
Blood Pressure Stabilizing Hormone Administered To Trauma Patients Reduces Transfusion Requirements By 50%, Study Finds
